Everest Medicines gets NMPA approval for Cardamyst NDA in adult PSVT
Everest Medicines Limited says China’s NMPA approved its Cardamyst (etripamil) NDA for treating PSVT in adults.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.